Utah Medical Products (NASDAQ:UTMD) Releases Earnings Results

Utah Medical Products (NASDAQ:UTMD - Get Free Report) issued its quarterly earnings results on Tuesday. The medical instruments supplier reported $0.92 EPS for the quarter, Zacks reports. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%. The firm had revenue of $9.71 million during the quarter.

Utah Medical Products Price Performance

UTMD traded up $0.85 during trading on Friday, hitting $53.05. The company had a trading volume of 866 shares, compared to its average volume of 20,004. Utah Medical Products has a 1-year low of $51.26 and a 1-year high of $77.33. The company has a market cap of $174.11 million, a PE ratio of 13.41 and a beta of 0.17. The business has a 50-day moving average of $55.69 and a 200-day moving average of $60.57.

Utah Medical Products Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, April 3rd. Stockholders of record on Friday, March 14th were given a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.30%. The ex-dividend date was Friday, March 14th. Utah Medical Products's payout ratio is currently 30.89%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.